SCHEMBL27475142

SCHEMBL27475142

CCCc1cc2ccc(C)cc2[nH]1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.51
RXFP1 Q9HBX9 1/20 0.51
HSD17B10 Q99714 8/20 0.48
ALDH1A1 P00352 7/20 0.48
KDM4E B2RXH2 6/20 0.48
HPGD P15428 5/20 0.48
GAA P10253 2/20 0.48
GLA P06280 1/20 0.48
LOXL2 Q9Y4K0 1/20 0.47
DAO P14920 1/20 0.46
DDO Q99489 1/20 0.46
TSHR P16473 3/20 0.44
POLB P06746 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C19 P33261 1/20 0.44
PCSK9 Q8NBP7 1/20 0.42
KMT2A Q03164 4/20 0.42
CA12 O43570 1/20 0.42
CA9 Q16790 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10412904 0.85 MAPT (0.64) MAPTRXFP1HSD17B10ALDH1A1KDM4E
SCHEMBL31406127 0.84 LOXL2 (0.54) MAPTRXFP1HSD17B10ALDH1A1KDM4E
SCHEMBL11806220 0.84 LOXL2 (0.54) MAPTRXFP1HSD17B10ALDH1A1KDM4E
SCHEMBL28264276 0.80 ADORA1 (0.41) MAPTRXFP1ALDH1A1KDM4EGAA
SCHEMBL29991879 0.80 GHSR (0.46) KDM4EDAODDOTSHRCYP2C19
SCHEMBL16240933 0.80 EGFR (0.52) MAPTRXFP1HSD17B10ALDH1A1KDM4E
SCHEMBL25505982 0.79 MAPT (0.53) MAPTRXFP1HSD17B10ALDH1A1KDM4E
SCHEMBL31017907 0.79 LOXL2 (0.73) MAPTRXFP1HSD17B10ALDH1A1KDM4E
SCHEMBL27732761 0.78 MAPT (0.39) MAPTRXFP1HSD17B10ALDH1A1KDM4E
SCHEMBL30610463 0.77 LOXL2 (0.60) MAPTALDH1A1KDM4ELOXL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024145483-A1 COMPOUNDS FOR USE IN THE TREATMENT OF CANCER AND METHODS OF MAKING AND USING THE SAME HTG MOLECULAR DIAGNOSTICS, INC. (US) 2024-07-04 WO disclosed